Agendia Files for IPO in Europe

The Dutch molecular diagnostics firm could raise more than $120 million in the offering on the NYSE Euronext in Amsterdam.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories